Lynne O'Keefe is a renowned name in the venture capital industry, having served as a partner in the Life Sciences Group at Kleiner Perkins Caufield & Byers. Her expertise in life sciences has helped numerous early-stage companies to achieve their full potential. With extensive experience in healthcare, Ms. O'Keefe has helped several startups in this field raise funds and reach their goals. She has played an instrumental role in several companies' growth, including ARMO BioSciences, which was acquired by Eli Lilly for $1.6 billion.

Ms. O'Keefe completed her undergraduate studies at Washington University in St. Louis and received an M.B.A. from Stanford Graduate School of Business. Before joining Kleiner Perkins, she worked at Goldman Sachs in investment banking and at Genentech in business development.